REFERENCES
- Chesrow, E. J., Giacobe, A. J. and Wosika, P. H.: Metrazol in arteriosclerosis associated with senility. Geriatrics 6: 319–323 (September-October) 1951.
- Fong, T. C. C.: Oral Metrazol therapy in psychoses with cerebral arteriosclerosis. J. Am. Geriatrics Soc. 1: 662–664 (September) 1953.
- Andosca, J. B.: Effects of pentylenetetrazol on senile patients. New England J. Med. 250: 461–463 (March 18) 1954.
- Smigel, J. O., Serhus, L. N. and Barmak, S.: Metrazol—its place in geriatric therapy. J. M. Soc. New Jersey 50: 248–252 (June) 1953.
- Smigel, J. O.: Modern drug therapy in mentally confused institutionalized patients. M. Times 84: 498–506 (May) 1956.
- Linden. M. E., Courtney, D. and Howland, A. O.: Interdisciplinary research in the use of oral pentylenetetrazol (Metrazol) in the emotional disorders of the aged. J. Am. Geriatrics Soc. 4: 380–399 (April) 1956.
- Tennent, J. J.: Experiences with Metrazol in psychoses with cerebral arteriosclerosis. Psychiatric Quart. 30: 249–259 (April) 1956.
- Esplin, D. W. and Curto, E. M.: Effects of trimethadione on synaptic transmission in the spinal cord; antagonism between trimethadione and pentylenetetrazol. Federation Proc. 16: 294 (March) 1957.